Skip to main content
Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
6.27
+0.21 (3.47%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Syros Pharmaceuticals Revenue

Syros Pharmaceuticals had revenue of $6.98M in the twelve months ending March 31, 2024. In the year 2023, Syros Pharmaceuticals had annual revenue of $9.94M.

Revenue (ttm)
$6.98M
Revenue Growth
-43.55%
P/S Ratio
24.01
Revenue / Employee
$102,662
Employees
68
Market Cap
167.59M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.94M-4.94M-33.23%
Dec 31, 202214.88M-8.61M-36.65%
Dec 31, 202123.49M8.40M55.62%
Dec 31, 202015.09M13.11M661.50%
Dec 31, 20191.98M-68.00K-3.32%
Dec 31, 20182.05M949.00K86.19%
Dec 31, 20171.10M784.00K247.32%
Dec 31, 2016317.00K--
Dec 31, 2015317.00K--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SYRS News

More News